(2025)
Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases.
ADVANCED HEALTHCARE MATERIALS.
14,
28
(2025)
Monitoring the Dynamics of Alzheimer's Disease Biomarkers and the APOE-Tau Axis via Human Cerebral Organoids with Immuno-SERS.
ADVANCED SCIENCE.
e,
05660
(2025)
Axially multifocal metalens for 3D volumetric photoacoustic imaging of neuromelanin in live brain organoid.
SCIENCE ADVANCES.
11,
3
(2024)
Advancements in brain organoid models for neurodegenerative disease research.
Organoid.
4,
e12
(2024)
3D bioprinting and label-free imaging: bridging innovations for organoid research.
INTERNATIONAL JOURNAL OF BIOPRINTING.
1,
1
(2024)
Hippocampal tau-induced GRIN3A deficiency in Alzheimer's disease.
FEBS OPEN BIO.
1,
1
(2024)
다중 혈액 바이오마커를 활용한 알츠하이머병 임상 진단 정확도의 향상.
Laboratory Medicine Online.
14,
4
(2024)
Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer's disease pathologies.
EXPERIMENTAL AND MOLECULAR MEDICINE.
56,
9
(2024)
Microglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2.
ADVANCED SCIENCE.
11,
34
(2024)
Electrophysiological insights with brain organoid models: a brief review.
BMB REPORTS.
57,
7
(2024)
Guidelines for Manufacturing and Application of Organoids: Brain.
INTERNATIONAL JOURNAL OF STEM CELLS.
17,
2
(2023)
Sex differences in the progression of glucose metabolism dysfunction in Alzheimer's disease.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
5
(2022)
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease.
CELL REPORTS.
40,
12
(2022)
Multi-Omics-Based Autophagy-Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology.
ADVANCED SCIENCE.
9,
23
(2022)
Neurotoxicity of phenylalanine on human iPSC-derived cerebral organoids..
MOLECULAR GENETICS AND METABOLISM.
136,
2
(2022)
Application of QPLEXTM biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition.
EXPERIMENTAL AND MOLECULAR MEDICINE.
54,
1
(2021)
The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit.
EXPERIMENTAL AND MOLECULAR MEDICINE.
53,
6
(2021)
A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids.
NATURE COMMUNICATIONS.
12,
1
(2021)
Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition.
ALZHEIMERS RESEARCH & THERAPY.
13,
1
(2024)
Current strategies for brain organoid-based drug screening platform with bioconvergence methods.
2024 대한약학회 추계국제학술대회.
대한민국
(2024)
Sex differences in the progression of glucose metabolism dysfunction in Alzheimer's disease.
2024 KSBNS-APSN International Conference.
대한민국
(2024)
Brain Organoid-based Bioconvergence Research for Neurological Diseases.
BIO Asia-Taiwan 2024 International Conference.
대만
(2024)
Current Strategies for brain organoid-based drug screening platform with bio-convergence methods.
2024 한국동물실험대체법학회.
대한민국
(2024)
Utilizing a Brain Organoid Model with Microglia to Uncover Proteopathy in Alzheimer’s Disease.
2024 KSBMB 동계학술대회.
대한민국
(2023)
Functional brain organoid-based precision medicine platform for neurodegenerative diseases.
2023년 제15회 대한퇴행성신경질환학회 학술대회.
대한민국
(2023)
Unveiling the Quantum Secrets of the Brain: Integrating Brain Organoids and Quantum Biology for Future Neurodegenerative Disease Research.
World Innovation Summit for Neurodegenerative Diseases Opportunities and Challenges in Medicine: WISDOM.
대한민국
(2023)
Brain organoid-based bioconvergence researches for precision medicine.
2023 오가노이드학회 춘계학술대회.
대한민국
발전기금
